Ubio Biotechnology Systems Profile
Key Indicators
- Authorised Capital ₹ 1.67 Cr
- Paid Up Capital ₹ 1.43 Cr
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.25 Cr
- Satisfied Charges ₹ 5.30 M
- Revenue Growth -69.98%
- Profit Growth -99.53%
- Ebitda -107.39%
- Net Worth 0.52%
- Total Assets -4.69%
About Ubio Biotechnology Systems
Ubio Biotechnology Systems Private Limited (UBSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 July 2008 and has a history of 16 years and seven months. Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.67 Cr and a paid-up capital of Rs 1.43 Cr.
The company currently has active open charges totaling ₹2.25 Cr. The company has closed loans amounting to ₹5.30 M, as per Ministry of Corporate Affairs (MCA) records.
Ravinder Qasba, Bishor Varakukalayil, and Brij Qasba serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72200KL2008PTC022851
- Company No.
022851
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Ubio Biotechnology Systems?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bishor Varakukalayil  | Managing Director | 23-Jul-2008 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravinder Qasba | Director | 28-Feb-2014 | Current |
| Brij Qasba | Whole-Time Director | 28-Feb-2014 | Current |
Financial Performance of Ubio Biotechnology Systems.
Ubio Biotechnology Systems Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 69.98% decrease. The company also saw a substantial fall in profitability, with a 99.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ubio Biotechnology Systems?
In 2023, Ubio Biotechnology Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pamposh Foods India Private LimitedRavinder Qasba and Brij Qasba are mutual person
Ivet Labs LlpBishor Varakukalayil is a mutual person
- Lumid Bio Private Limited
Bishor Varakukalayil is a mutual person
- Biosix Peptides (India) Private Limited
Bishor Varakukalayil is a mutual person
- Aegle Scientific Private Limited
Bishor Varakukalayil is a mutual person
- Vetragen Healthcare Private Limited
Bishor Varakukalayil is a mutual person
Charges (Loans)
₹2.25 Cr
₹0.53 Cr
Charges Breakdown by Lending Institutions
- Others : 2.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2022 | Others | ₹2.25 Cr | Open |
| 29 Nov 2013 | State Bank Of India | ₹2.40 M | Satisfied |
| 19 Jul 2011 | State Bank Of India | ₹2.90 M | Satisfied |
How Many Employees Work at Ubio Biotechnology Systems?
Unlock and access historical data on people associated with Ubio Biotechnology Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ubio Biotechnology Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ubio Biotechnology Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
